Stock ALRN AILERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
3.76 USD -1.57% Intraday chart for Aileron Therapeutics, Inc. -24.80% +23.34%
05-03 Aileron Therapeutics Closes Direct Offering of Shares, Warrants MT
05-01 Transcript : Aileron Therapeutics, Inc. - Special Call

Evolution of the average Target Price on Aileron Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c5179c673414.S_Fy4HjdegmGEnZu67F6wiUx0ifpFJnLhlMQXhBIMSg.JrARoxmuT1jQfSI8keA7hGl8gUK9Zsv_swx2MXYaZmEJpwWLMek4Zb9xFQ~0aee51339d402f72195460ee6eaabe3a

Analyst Recommendations on Aileron Therapeutics, Inc.

Ladenburg Thalmann Adjusts Aileron Therapeutics Price Target to $19 From $9, Maintains Buy Rating MT
Ladenburg Thalmann Upgrades Aileron Therapeutics to Buy From Neutral, Price Target is $9 MT
HC Wainwright Downgrades Aileron Therapeutics to Neutral From Buy MT
Jones Trading Downgrades Aileron Therapeutics to Neutral from Buy MT
HC Wainwright Adjusts Price Target on Aileron Therapeutics to $1 From $2, Reiterates Buy Rating MT
Ladenburg Thalmann Initiates Coverage on Aileron Therapeutics With Buy Rating, $2 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.76 USD
Average target price
19 USD
Spread / Average Target
+405.32%
High Price Target
19 USD
Spread / Highest target
+405.32%
Low Price Target
19 USD
Spread / Lowest Target
+405.32%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aileron Therapeutics, Inc.

Ladenburg Thalmann
HC Wainwright
JonesTrading Institutional Services

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALRN Stock
  4. Consensus Aileron Therapeutics, Inc.